1. Iliopsoas hematoma as a complication of tetanus.
- Author
-
Ishii, Nobuyuki, Mochizuki, Hitoshi, Shiomi, Kazutaka, and Nakazato, Masamitsu
- Abstract
Background: Iliopsoas hematoma is a rare but serious bleeding event that occurs during anticoagulation therapy. Due to lack of previous reports of clinical data, incidence and characteristics of iliopsoas hematoma during tetanus management, including anticoagulation prophylaxis for venous thromboembolism, remain unclear. Aim: To evaluate the incidence of iliopsoas hematoma in tetanus and identify clinical factors that would help in its detection. Materials and Methods: We conducted a retrospective descriptive study and evaluated the clinical courses of patients with iliopsoas hematoma as a case series. Patient data were collected by reviewing medical charts. Results: Among 21 patients, four (19%) developed iliopsoas hematoma during the clinical course of tetanus. A case series of these four patients revealed that all had progressive anemia; furthermore, D‐dimer levels continued increasing or did not decrease in these patients despite them receiving anticoagulation therapy. Conclusion: The incidence of tetanus‐related iliopsoas hematoma was higher than that of anticoagulation‐related iliopsoas hematoma. Therefore, clinicians should carefully consider the indication of prophylaxis for venous thromboembolism in patients with tetanus. Progressive anemia and increased D‐dimer level may indicate iliopsoas hematoma in patients with tetanus. [ABSTRACT FROM AUTHOR]
- Published
- 2019
- Full Text
- View/download PDF